Grofoni et al. also found that ~70% and 100% of COVID-19 convalescent subjects with mild and severe symptoms developed SARS-CoV-2-specific CD8+ and CD4+ T cells, respectively (6). The gene discussed is CD4; the disease is COVID-19.